Verition Fund Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,472
| Closed | -$482K | – | 2811 |
|
|
2024
Q4 | $482K | Sell |
13,472
-38,658
| -74% | -$1.38M | ﹤0.01% | 1909 |
|
|
2024
Q3 | $2.46M | Buy |
52,130
+51,688
| +11,694% | +$2.44M | 0.01% | 915 |
|
|
2024
Q2 | $22.2K | Sell |
442
-22,125
| -98% | -$1.11M | ﹤0.01% | 2210 |
|
|
2024
Q1 | $2.53M | Buy |
+22,567
| New | +$2.53M | 0.02% | 773 |
|
|
2023
Q4 | – | Sell |
-6,538
| Closed | -$208K | – | 2104 |
|
|
2023
Q3 | $208K | Buy |
+6,538
| New | +$208K | ﹤0.01% | 1611 |
|
|
2022
Q4 | – | Sell |
-652
| Closed | -$110K | – | 1996 |
|
|
2022
Q3 | $110K | Buy |
+652
| New | +$110K | ﹤0.01% | 2006 |
|